- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 365192, 6 pages
The Possible Role of Mena Protein and Its Splicing-Derived Variants in Embryogenesis, Carcinogenesis, and Tumor Invasion: A Systematic Review of the Literature
1Department of Pathology, University of Medicine and Pharmacy of Targu-Mures, 38 Ghe Marinescu Street, 540193 Targu Mures, Romania
2Department of Dermatology, University of Medicine and Pharmacy of Targu-Mures, 540193 Targu Mures, Romania
3Department of Public Health, University of Pecs, Medical School, Szigeti Street 12, Pecs 7624, Hungary
Received 7 April 2013; Revised 16 June 2013; Accepted 2 July 2013
Academic Editor: Claus-Peter Richter
Copyright © 2013 Simona Gurzu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- F. B. Gertler, K. Niebuhr, M. Reinhard, J. Wehland, and P. Soriano, “Mena, a relative of VASP and Drosophila enabled, is implicated in the control of microfilament dynamics,” Cell, vol. 87, no. 2, pp. 227–239, 1996.
- U. Philippar, E. T. Roussos, M. Oser et al., “A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis,” Developmental Cell, vol. 15, no. 6, pp. 813–828, 2008.
- M. Krause, E. W. Dent, J. E. Bear, J. J. Loureiro, and F. B. Gertler, “Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration,” Annual Review of Cell and Developmental Biology, vol. 19, pp. 541–564, 2003.
- F. Di Modugno, G. Bronzi, M. J. Scanlan et al., “Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response,” International Journal of Cancer, vol. 109, no. 6, pp. 909–918, 2004.
- F. Di Modungo, P. Iapicca, A. Boudreau et al., “Splicing program of human Mena produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 47, pp. 19280–19285, 2012.
- S. Goswami, U. Philippar, D. Sun et al., “Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo,” Clinical and Experimental Metastasis, vol. 26, no. 2, pp. 153–159, 2009.
- E. T. Roussos, Y. Wang, J. B. Wyckoff et al., “Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors,” Breast Cancer Research, vol. 12, no. 6, article R101, 2010.
- F. Di Modugno, M. Mottolese, A. Di Benedetto et al., “The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors,” Clinical Cancer Research, vol. 12, no. 5, pp. 1470–1478, 2006.
- F. Di Modugno, L. DeMonte, M. Balsamo et al., “Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines,” Cancer Research, vol. 67, no. 6, pp. 2657–2665, 2007.
- K. Tani, S. Sato, T. Sukezane et al., “Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-ABL kinase,” The Journal of Biological Chemistry, vol. 278, no. 24, pp. 21685–21692, 2003.
- A. V. Kwiatkowski, F. B. Gertler, and J. J. Loureiro, “Function and regulation of Ena/VASP proteins,” Trends in Cell Biology, vol. 13, no. 7, pp. 386–392, 2003.
- S. Higley and M. Way, “Actin and cell pathogenesis,” Current Opinion in Cell Biology, vol. 9, no. 1, pp. 62–69, 1997.
- S. Gambaryan, W. Hauser, A. Kobsar, M. Glazova, and U. Walter, “Distribution, cellular localization, and postnatal development of VASP and Mena expression in mouse tissues,” Histochemistry and Cell Biology, vol. 116, no. 6, pp. 535–543, 2001.
- G. Pula and M. Krause, “Role of Ena/VASP Proteins in Homeostasis and Disease,” in Protein-Protein Interactions as a New Drug Targets, E. Klussmann and J. Scott, Eds., pp. 39–66, Springer, Berlin, Germany, 2008.
- G. Cardinali, D. Kovacs, A. Mastrofrancesco et al., “hMena: altered expression in psoriatic skin,” Archives of Dermatological Research, 2013.
- S. L. Gupton, D. Riquelme, S. K. Hughes-Alford et al., “Mena binds α5 integrin directly and modulates α5β1 function,” Journal of Cell Biology, vol. 198, no. 4, pp. 657–676, 2012.
- A. Lambrechts, M. van Troys, and C. Ampe, “The actin cytoskeleton in normal and pathological cell motility,” International Journal of Biochemistry and Cell Biology, vol. 36, no. 10, pp. 1890–1909, 2004.
- M. Michael, A. Vehlow, C. Navarro, and M. Krause, “c-Abl, Lamellipodin, and Ena/VASP proteins cooperate in dorsal ruffling of fibroblasts and axonal morphogenesis,” Current Biology, vol. 20, no. 9, pp. 783–791, 2010.
- S. Gurzu, I. Jung, I. Prantner, I. Ember, Z. Pávai, and T. Mezei, “The expression of cytoskeleton regulatory protein Mena in colorectal lesions,” Romanian Journal of Morphology and Embryology, vol. 49, no. 3, pp. 345–349, 2008.
- I. Jung, S. Gurzu, I. Prantner, T. Mezei, and Z. Pavai, “Immunohistochemical expression of Mena in carcinomas and premalignant lesions of colon, stomach and thyroid gland,” Histopathology, vol. 53, no. 1, p. 140, 2008.
- S. Gurzu, I. Jung, I. Prantner, L. Chira, and I. Ember, “The immunohistochemical aspects of protein Mena in cervical lesions,” Romanian Journal of Morphology and Embryology, vol. 50, no. 2, pp. 213–216, 2008.
- S. Gurzu, I. Ember, M. Krause et al., “Mena, a new available marker in tumors of salivary glands?” European Journal of Histochemistry, vol. 56, no. 1, article e8, 2012.
- J. W. Du, K. Y. Xu, L. Y. Fang, and X. L. Qi, “Clinical significance of Mena and Her-2 expression in breast cancer,” European Journal of Gynaecological Oncology, vol. 33, no. 5, pp. 455–458, 2012.
- K. Takahashi and K. Suzuki, “WAVE2, N-WASP, and Mena facilitate cell invasion via phosphatidylinositol 3-kinase-dependent local accumulation of actin filaments,” Journal of Cellular Biochemistry, vol. 112, no. 11, pp. 3421–3429, 2011.
- A. Toyoda, H. Kawana, K. Azuhata et al., “Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression,” International Journal of Oncology, vol. 34, no. 1, pp. 53–60, 2009.
- A. Najafov, T. Seker, I. Even et al., “MENA is a transcriptional target of the Wnt/Beta-catenin pathway,” PLoS ONE, vol. 7, no. 5, Article ID e37013, 2012.
- M. S. Pino, M. Balsamo, F. D. Modugno et al., “Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines,” Clinical Cancer Research, vol. 14, no. 15, pp. 4943–4950, 2008.
- Y. Peng, E. L. Murray, M. Sarkar, X. Liu, and D. R. Schoenberg, “The cytoskeleton-associated Ena/VASP proteins are unanticipated partners of the PMR1 mRNA endonuclease,” RNA, vol. 15, no. 4, pp. 576–587, 2009.
- M. Eigenthaler, S. Engelhardt, B. Schinke et al., “Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy,” The American Journal of Physiology, vol. 285, no. 6, pp. H2471–H2481, 2003.
- F. Aguilar, S. L. Belmonte, R. Ram et al., “Mammalian enabled (Mena) is a critical regulator of cardiac function,” The American Journal of Physiology, vol. 300, no. 5, pp. H1841–H1852, 2011.
- J. E. Bear, J. J. Loureiro, I. Libova, R. Fässler, J. Wehland, and F. B. Gertler, “Negative regulation of fibroblast motility by Ena/VASP proteins,” Cell, vol. 101, no. 7, pp. 717–728, 2000.
- B. Schick, M. Praetorius, M. Eigenthaler et al., “Increased noise sensitivity and altered inner ear MENA distribution in VASP −/− mice,” Cell and Tissue Research, vol. 318, no. 3, pp. 493–502, 2004.
- D. M. Juriloff and M. J. Harris, “Mouse models for neural tube closure defects,” Human Molecular Genetics, vol. 9, no. 6, pp. 993–1000, 2000.
- T. Katsu, H. Ujike, T. Nakano et al., “The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia,” Neuroscience Letters, vol. 353, no. 1, pp. 53–56, 2003.
- M. Higashi, C. Ishikawa, J. Yu et al., “Human mena associates with Rac1 small GTPase in glioblastoma cell lines,” PLoS ONE, vol. 4, no. 3, Article ID e4765, 2009.
- E. Yanagida-Asanuma, K. Asanuma, K. Kim et al., “Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes,” The American Journal of Pathology, vol. 171, no. 2, pp. 415–427, 2007.
- T. Deller, M. Korte, S. Chabanis et al., “Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 18, pp. 10494–10499, 2003.
- E. S. Tobias, A. F. L. Hurlstone, E. MacKenzie, R. Mcfarlane, and D. M. Black, “The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein,” Oncogene, vol. 20, no. 22, pp. 2844–2853, 2001.
- A. S. Coutts, E. MacKenzie, E. Griffith, and D. M. Black, “TES is a novel focal adhesion protein with a role in cell spreading,” Journal of Cell Science, vol. 116, part 5, pp. 897–906, 2003.
- B. Boëda, D. C. Briggs, T. Higgins et al., “Tes, a specific Mena interacting partner, breaks the rules for EVH1 binding,” Molecular Cell, vol. 28, no. 6, pp. 1071–1082, 2007.